Both in Pharmaceuticals
ArriVent BioPharma vs Zevra Therapeutics
Over the past year AVBP returned −26.0% and ZVRA returned +0.5%; their daily moves had a correlation of 0.17.
AVBP −26.0% ZVRA +0.5%Growth of $1, one year, split-adjusted
| Metric | AVBP | ZVRA |
|---|---|---|
| Price | $13.02 | $10.26 |
| Market cap | $642.0M | $609.3M |
| Today | −2.47% | +1.58% |
| 1 month | −54.3% | −4.1% |
| 6 months | −56.4% | −3.3% |
| Year to date | −35.3% | +14.5% |
| 1 year | −30.5% | +0.8% |
| Revenue growth (YoY) | — | +53.3% |
| Gross margin | — | 96.2% |
| Net margin | — | 21.2% |
| P/E (TTM) | — | 10.5× |
| Price / sales | — | 4.5× |
| Net cash | $373.1M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 154.4% | 44.3% |
| Short % of float | 20.3% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).